Skip to content

Clinical trials

Observational Respiratory Syncytial Virus Infections trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Syncytial Virus Infections Phase: Observational Country / region: United States Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20052
20061
20072
20111
20121
20151
20192
20201
20221
20237
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Unknown status2
Recruiting1
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
LumiraDx UK Limited2
MedImmune LLC2
Baebies, Inc.1
Duke University1
Gilead Sciences1
Janssen Pharmaceutica N.V., Belgium1
National Institute of Allergy and Infectious Diseases (NIAID)1
QIAGEN Gaithersburg, Inc1
Sanofi Pasteur, a Sanofi Company1
Sequenom, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiratory Syncytial Virus Infections23
COVID-195
Influenza, Human4
Respiratory Tract Infections3
Asthma2
Coronavirus Infections2
Acute Lung Injury1
Adenoviridae Infections1
Bronchiolitis1
Coxsackievirus Infections1

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.